DE
PFE icon

DV Equities’s Pfizer PFE Stock Holding History

DV Equities’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$198K Buy
+7,932
New +$200K 0.04% 136

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

DV Equities's PFE Position: Q4 2025 in Review

DV Equities opened a new position in Pfizer (PFE) in Q4 2025: 7,932 shares worth $198K. The stake represents 0.04% of the portfolio and ranks #136 among its holdings.

2,913 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • DV Equities held 7,932 shares of Pfizer worth $198K as of Q4 2025.
  • Pfizer was a new DV Equities position in Q4 2025.
  • Pfizer made up 0.04% of DV Equities's portfolio in Q4 2025, its #136 holding.
  • 2,913 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on DV Equities's 13F filing for Q4 2025, filed 17 Feb 2026.